Diabetes and hyperlipidemia induce dysfunction of VSMCs: Contribution of the metabolic inflammation/miRNA pathway

American Journal of Physiology - Endocrinology and Metabolism

Volumn 308, Issue 4, 2015, Pages E257-E269

  Li, Tao ^a   Yang, Guang Ming ^a   Zhu, Yu ^a   Wu, Yue ^a   Chen, Xiang Yun ^a   Lan, Dan ^a   Tian, Kun Lun ^a   Liu, Liang Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Metabolic disease; MicroRNA; Rho kinase; Vascular contraction; Vascular smooth muscle cells

Indexed keywords

FASUDIL; GLUCOSE; LIPID; MICRORNA; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; GAP JUNCTION PROTEIN; METFORMIN; PROTEIN KINASE INHIBITOR; RHO KINASE; SIMVASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERLIPIDEMIA; INFLAMMATION; LIPID BLOOD LEVEL; MALE; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DRUG COMBINATION; DRUG EFFECTS; GENETICS; HYPERLIPIDEMIAS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RENAL ARTERY; SPRAGUE DAWLEY RAT; VASCULITIS;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; CELLS, CULTURED; CONNEXINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DRUG THERAPY, COMBINATION; FEMALE; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; MALE; METFORMIN; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASE INHIBITORS; RATS, SPRAGUE-DAWLEY; RENAL ARTERY; RHO-ASSOCIATED KINASES; SIMVASTATIN; VASCULITIS;

EID: 84922892810     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00348.2014     Document Type: Article

References (30)

1. Boyle AJ, Whitbourn R, Schlicht S, Krum H, Kocher A, Nandurkar H, Bergmann S, Daniell M, O’Day J, Skerrett D, Haylock D, Gilbert RE, Itescu S. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up. Int J Cardiol 109: 21- 27, 2006.
2. Chung JH, Jeon HJ, Hong SY, Lee DL, Lee KH, Kim SH, Han YS, Manabe I, Miller YI, Lee SH. Palmitate promotes the paracrine effects of macrophages on vascular smooth muscle cells: the role of bone morpho-genetic proteins. PLoS One 29: 100-111, 2012.
3. Cifarelli V, Luppi P, Tse HM, He J, Piganelli J, Trucco M. Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kapa B activation in vascular smooth muscle cells. Atherosclerosis 201: 248-257, 2008.
4. Diniz GP, Takano AP, Barreto-Chaves ML. MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/a-MHC modulation. Mol Cell Endocrinol 374: 117-124, 2013.
5. Drawnel FM, Wachten D, Molkentin JD, Maillet M, Aronsen JM, Swift F, Sjaastad I, Liu N, Catalucci D, Mikoshiba K, Hisatsune C, Okkenhaug H, Andrews SR, Bootman MD, Roderick HL. Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. J Cell Biol 199: 783-798, 2012.
6. Duong-Quy S, Bei Y, Liu Z, Dinh-Xuan AT. Role of Rho-kinase and its inhibitors in pulmonary hypertension. Pharmacol Ther 137: 352-364, 2013.
7. Gilbert RE. Endothelial loss and repair in the vascular complications of diabetes: pathogenetic mechanisms and therapeutic implications. Circ J 177: 849-856, 2013.
8. Jaumdally RJ, Goon PK, Varma C, Blann AD, Lip GY. Effects of atorvastatin on circulating CD34+/CD133+/CD45— progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angio-poietins 1 and 2) in atherosclerotic vascular disease and diabetesmellitus. J Intern Med 267: 385-393, 2010.
9. Kitazawa T, Eto M, Woodsome TP, Brautiqan DL. Agonists trigger G protein mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275: 9897-9900, 2000.
10. Kobayashi Y, Naruse K, Hamada Y, Nakashima E, Kato K, Akiyama N, Kamiya H, Watarai A, Nakae M, Oiso Y, Nakamura J. Human proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells cultured in high-glucose conditions. Diabetologia 48: 2396-2401, 2005.
11. Lamers D, Schlich R, Greulich S, Sasson S, Sell H, Eckel J. Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells. J Cell Mol Med 15: 1177-1188, 2011.
12. Li T, Fang YQ, Yang GM, Xu J, Zhu Y, Liu LM. Effects of the balance in activity of RhoA and Rac1 on the shock-induced biphasic change of vascular reactivity in rats. Ann Surg 253: 185-193, 2011.
13. Li T, Liu LM, Liu JC, Ming J, Xu J, Yang GM. Mechanisms of Rho kinase regulation of vascular reactivity following hemorrhagic shock. Shock 29: 65-70, 2008.
14. Madsen CR, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab 17: 20-33, 2013.
15. McClung JA, Naseer N, Saleem M, Rossi GP, Weiss MB, Abraham NG, Kapas A. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA1c. Diabetologia 48: 345-350, 2005.
16. Meerson A, Traurig M, Ossowski V, Fleming JM, Mullins M, Baier LJ. Human adipose microRNA-221 is up-regulated in obesity and affects fat metabolism downstream of leptin and TNF-a. Diabetologia 56: 1971– 1979, 2013.
17. Ming J, Li T, Xu J, Yang GM, Zhang Y, Liu LM. Regulation effects of MEGJ on vasoconstrictor reactivity following hemorrhagic shock in rats. Shock 31: 80-86, 2009.
18. Nakamura J, Kasuya Y, Hamada Y, Nakashima E, Naruse K, Yasuda Y, Kato K, Hotta N. Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity. Diabetologia 44: 480–487, 2001.
19. Naraoka M, Munakata A, Matsuda N, Shimamura N, Ohkuma H. Suppression of the Rho/Rho-kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit. Transl Stroke Res 4: 368-374, 2013.
20. Nathan DM, Bayless M, Cleary P, Genuth S, Gubitosi-Klug R, Lachin JM, Lorenzi G, Zinman B. Diabetes control and complications trial/ epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes 62: 3976-3986, 2013.
21. Porter KE, Riches K. The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes? Clin Sci 125: 167-182, 2013.
22. Rong JX, Shapiro M, Trogan E, Fisher EA. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA 100: 13531-13536, 2003.
23. Ruan W, Xu JM, Li SB, Yuan LQ, Dai RP. Effects of down-regulation of microRNA-23a on TNF-a-induced endothelial cell apoptosis through caspase-dependent pathways. Cardiovasc Res 93: 623-632, 2012.
24. Shenouda SM, Widlansky ME, Chen K, Xu G, Holbrook M, Tabit CE, Hamburg NM, Frame AA, Caiano TL, Kluge MA, Duess MA, Levit A, Kim B, Hartman ML, Joseph L, Shirihai OS, Vita JA. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation 124: 444–453, 2011.
25. Simon AM, McWhorter AR. Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 251: 206-220, 2002.
26. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell 126: 1037-1048, 2006.
27. Xu J, Li T, Yang GM, Liu LM. PKC isoforms responsible for the regulation of vascular calcium sensitivity and their relationship to ilk pathway after hemorrhagic shock. J Trauma 69: 1274-1281, 2010.
28. Xu WD, Zhang YJ, Ye DQ. Evidence for a role of microRNA-146a in the pathogenesis of systemic lupus erythematosus with atherosclerosis: comment on the article by Li et al. Arthritis Rheum 64: 323-324, 2012.
29. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107: 810-817, 2010.
30. Zhang X, Zhang B, Gao J, Wang X, Liu Z. Regulation of the microRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis. J Biol Chem 288: 32742-2752, 2013.